Description The purpose of this best practice advice article is to describe the role of Barrett's
endoscopic therapy (BET) in patients with Barrett's esophagus (BE) with dysplasia and/or …

The incidence of esophageal cancer (EC) is on the rise. With the distinct subtypes of
adenocarcinoma and squamous cell carcinoma comes specific risk factors, and as a result …

METHODS: In a prospective clinical trial, 11 academic and community centers recruited
consecutive patients with BE of 1–6 cm length and low-grade dysplasia, high-grade …

Background and Aims Strong evidence supports the use of radiofrequency ablation (RFA) in
the management of dysplastic/neoplastic Barrett's esophagus (BE). Recently, the efficacy of …

In this paper, I reviewed the emerging field of endoscopic surgery and present data
supporting the contention that endoscopy can now be used to treat many foregut diseases …

Since Barrett's esophagus is a precancerous condition, efforts have been made for its
eradication by various ablative techniques. Initially, laser ablation was attempted in non …

Introduction: Cryotherapy is a cold-based ablative therapy used primarily as second line
therapy in patients with Barrett's esophagus (BE) who have persistent dysplasia after …

EET is now standard of care and endorsed by societal guidelines for the treatment of
Barrett's oesophagus related neoplasia. Future studies should focus on risk stratification …

Radiofrequency ablation (RFA) is the preferred treatment option for Barrett's esophagus (BE)
to achieve complete eradication (CE) of dysplasia (D), and intestinal metaplasia (IM) …

Intestinal metaplasia refers to the replacement of the differentiated and mature normal
mucosal epithelium outside the intestinal tract by the intestinal epithelium. This paper briefly …